BB trial; Effect of botox in Piriformis syndrome
Phase 1
- Conditions
- piriformis hypertoniaTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
- Registration Number
- CTIS2023-504427-61-01
- Lead Sponsor
- Stichting Alrijne Zorggroep
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Positive effect of the test block with lidocaine and methylprednisolone -Age between 18-60 years old -Active participation in a sport where walking may also be considered
Exclusion Criteria
-Botox injection in the piriformis less than three months ago -Other injections in the piriformis less than three months ago
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method